Ozempic and Wegovy Users Face Weight Regain Warning Within 18 Months Thursday, April 30, 2026 ozempic wegovy glp-1 weightloss obesity semaglutide weightregain diabetes cardiometabolic pharmaceutical Recent research reveals that individuals discontinuing GLP-1 medications such as Ozempic and Wegovy can expect to regain the weight they lost within approximately 18 months. An analysis of 37 previous studies involving 9,000 … Read More
Ozempic and Wegovy Users Face Weight Regain Risk Within 18 Months Thursday, April 30, 2026 ozempic wegovy glp-1 weightloss semaglutide obesity weightgain cardiovascular diabetes medications People who stop taking GLP-1 medications—such as Ozempic, Wegovy, and other similar weight-loss drugs—are likely to regain the weight they lost within about 18 months, according to a comprehensive study. This research, which … Read More
Weight-loss jabs could 'significantly lower' risk of dementia Wednesday, June 25, 2025 semaglutide dementia ozempic wegovy diabetes alzheimers glp1 weightloss cardiovascular t2diabetes A groundbreaking study has found that semaglutide, the active ingredient in the diabetes drug Ozempic and the weight-loss injection Wegovy, may significantly reduce the risk of dementia in people with type 2 diabetes. … Read More
Weight-Loss Injections May Dramatically Reduce Dementia Risk Wednesday, June 25, 2025 dementia semaglutide ozempic wegovy type2diabetes alzheimers glp1r weightloss cardiovascular prevention A groundbreaking study suggests that semaglutide, the active ingredient in diabetes drug Ozempic and weight-loss injection Wegovy, could significantly decrease the risk of dementia in individuals with type 2 diabetes. … Read More
Weight-loss jab Mounjaro outperforms rival Wegovy in major study Sunday, May 11, 2025 mounjaro wegovy weightloss obesity tirzepatide semaglutide clinicaltrial glp1 gip diabetes A groundbreaking study has found that the weight-loss drug Mounjaro (tirzepatide) helps patients lose significantly more weight than its competitor, Wegovy (semaglutide). Presented at the European Congress on Obesity in … Read More
The Surprising Oral Health Side Effects of Weight Loss Drugs Sunday, May 4, 2025 weight loss drugs oral health side effects dentist medication glp-1 ozempic wegovy mounjaro saliva dental hygiene Weight loss medications such as GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have garnered attention for their effectiveness in slimming down waistlines. However, leading dentist Dr. Sofina Ahmed of Viva Dental warns of … Read More